Literature DB >> 24449313

Opening the FDA black box.

Steven N Goodman1, Rita F Redberg2.   

Abstract

Mesh：

Year:  2014        PMID： 24449313     DOI： 10.1001/jama.2013.283946

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?

Authors:  Andre M Samuel; Vinay K Rathi; Jonathan N Grauer; Joseph S Ross
Journal:  Clin Orthop Relat Res       Date:  2015-11-19       Impact factor: 4.176

Review 2.  Approval of high-risk medical devices in the US: implications for clinical cardiology.

Authors:  Benjamin N Rome; Daniel B Kramer; Aaron S Kesselheim
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

Review 3.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

Authors:  Paul J Martin; Stephanie J Lee; Donna Przepiorka; Mary M Horowitz; John Koreth; Georgia B Vogelsang; Irwin Walker; Paul A Carpenter; Linda M Griffith; Gorgun Akpek; Mohamad Mohty; Daniel Wolff; Steven Z Pavletic; Corey S Cutler
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-15       Impact factor: 5.742

4.  Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.

Authors:  Satish Sharan; Sukyung Woo
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

5.  ArthroplastyWatch.com three-year follow-up: where do we stand now?

Authors:  Ann Alriksson-Schmidt; Jonas Ranstam; Otto Robertsson; Lars Lidgren
Journal:  EFORT Open Rev       Date:  2017-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.